biopharmaceutical


Also found in: Dictionary, Wikipedia.
Related to biopharmaceutical: biotechnology

biopharmaceutical

(bī′ō-fär′mə-so͞o′tĭ-kəl)
n.
A drug produced by means of biotechnology, consisting of a large, complex molecule such as a protein rather than a small molecule.
adj.
1. Of or relating to a drug or drugs produced by means of biotechnology: the biopharmaceutical industry.
2. Of or relating to properties of pharmaceutical preparations and their effects after administration: biopharmaceutical factors affecting intestinal absorption of the drug.

biopharmaceutical

A generic term for a biomolecule (e.g., proteins), including antibodies and nucleic acids and antisense oligonucleotides, which are produced in a transgenic organism—e.g., mice, livestock, fish, or plant—and used as a therapeutic agent.
References in periodicals archive ?
Our Shanghai facility plays an important role in our globally leading biopharmaceutical contract manufacturing business and embodies our continuous and long-term commitment to China," said Hubertus von Baumbach, chairman of the board of managing directors, Boehringer Ingelheim.
The clincher for Vienna was ultimately the companys desire to additionally secure the market supply of biopharmaceutical products and to balance the risk by establishing a further independent facility.
BioPartners, Baar, Switzerland, a privately-owned biopharmaceuticals company has expressed disappointment that its biosimilar Interferon Alpha, Alpheon(R), had received a negative opinion from the European Medicines Agency's Committee on Medicinal Products for Human Use (CHMP).
WASHINGTON -- The Generic Pharmaceutical Association says "sound science" supports the marketing of generic biopharmaceuticals, and it has called on the Food and Drug Administration to accelerate the approval of affordable biopharmaceuticals.
In China, the veterinary vaccine belongs to not the biopharmaceutical industry but the realm of the veterinary drug.
The Global Biopharmaceutical Industry has come a long way since its first drug- Humulin was approved in 1982.
The author spent two months to interview a large number of China's biopharmaceutical manufacturers and wrote this report depending on abundant second-hand information.
In 2008, the market size of China's biopharmaceutical industry was about 70 billion Yuan (about 10 billion US Dollars), where the growth rate passed the whole market size of China's medicine market and also above three sub-sectors including chemical medicine materials, chemical medicine dose and traditional Chinese prepared medicines.
The report has analyzed China's biopharmaceutical industry in terms of production and sales, import and export, sub-sectors and development trend.
Compared with traditional pharmaceutical industry, biopharmaceutical industry sees a higher market concentration, and this is more helpful for strong enterprises to grow stronger and for building a number of leading enterprises in the segment areas.
William Downey, President of HighTech Business Decisions, explains, "We extensively interviewed 41 directors of biomanufacturing at pharmaceutical and biotechnology companies worldwide, and 27 biopharmaceutical contract manufacturers.
is a biopharmaceutical company focused on the development of late-stage "disruptive" clinical products, especially for already-approved drugs in new formulations and/or new indications that are patent-protected and which represent new therapeutics with greater clinical and economic value.